Levobens (Benserazide Hydrochloride, Levodopa)

Levodopa is a precursor that crosses the blood‑brain barrier and is converted into dopamine, the neurotransmitter deficient in Parkinson's disease. Benserazide inhibits the peripheral conversion of levodopa, ensuring more of the drug reaches the brain where it can be transformed into dopamine.

The dosage of Levobens is individualized by the prescribing clinician based on the patient’s disease stage, response, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule for each patient.

Safety data for levodopa/benserazide in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Levobens, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levobens combines levodopa with a peripheral decarboxylase inhibitor, offering higher central availability of levodopa compared with levodopa alone. This can provide more consistent symptom control than some dopamine agonists, though individual response and side‑effect profiles vary among patients.

Levobens tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect from moisture and light, and discard any tablets that appear discoloured or damaged.

Levobens is taken orally, usually with a glass of water. It can be taken with or without food, but a consistent routine helps maintain stable drug levels. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include neuroleptic malignant syndrome, severe psychiatric disturbances such as hallucinations or psychosis, and cardiac arrhythmias. Any sudden fever, rigidity, confusion, or irregular heartbeat should prompt immediate medical attention.

Levobens is contraindicated in patients with known hypersensitivity to levodopa, benserazide, or any excipients, and in those taking non‑selective monoamine oxidase inhibitors. Caution is also advised for individuals with uncontrolled cardiovascular disease, severe hepatic or renal impairment, and certain psychiatric conditions.